Marriott Harrison was pleased to support Redalpine on their investment into Uncommon, leading the way in developing scalable cultivated meat. The round was led by Balderton Capital and Lowercarbon Capital, with participation from East Alpha, and previous investors Max and Sam Altman, Miray Zaki and Sebastiano Castiglioni.
Uncommon uses patent-pending RNA technology allowing them to create clean cultivated bacon and pork belly from a single animal cell sample, enabling them to quickly achieve an equal price with conventional meat and giving them an advantage over competitors in the market. They will use their funding to scale up their production at their manufacturing facility, initiate regulatory approval processes, and grow their team.
Redalpine is a Swiss VC that empowers game changers. Since 2006, the firm has backed over 85 companies through seven funds. It has invested in some of Europe’s most ambitious startups, guiding companies from early stage to market leaders. Redalpine’s mission statement aligns with Marriott Harrison’s commitment to working alongside companies that shape the future.